Compass Therapeutics
phase combination study status | Compass Therapeutics
Company
Deck Type
Sector
Industry
Deck date
May 2022
Slide
30 of 36
Related slides by other companies
DICE Therapeutics
Investor Presentation
March 2023
key from phase efficacy results dice | DICE Therapeutics
BioAtla
Investor Presentation
January 2024
cab phase mono and study currently underway | BioAtla
RenovoRx
IPO
August 2021
promising data from phase and observational registry studies advanced clinical development program to phase | RenovoRx
RenovoRx
IPO
August 2021
designed for success one phase trial to approval pivotal tiger pac phase study schema currently enrolling | RenovoRx
Other recent decks by Compass Therapeutics
See all presentations (6 decks)
Investor Presentation
May 2023
Investor Presentation
February 2023
Investor Presentation
January 2023
Investor Presentation
May 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights